eGenesis
eGenesis is a clinical-stage biotechnology company based in Cambridge, Massachusetts, developing human-compatible, genetically engineered organs to address the global organ shortage. Using a proprietary CRISPR-based multiplex genome-editing platform, eGenesis modifies the porcine genome to inactivate endogenous retroviruses and add protective human transgenes, producing pig kidneys, livers, and hearts intended for xenotransplantation. Its lead program, EGEN-2784, is a genetically engineered porcine kidney being evaluated in an expanded-access study. This API Evangelist profile tracks the company; eGenesis publishes no public developer API.
eGenesis is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Xenotransplantation, Gene Editing, and CRISPR.
eGenesis’ developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API